Superior sulcus lung tumors: Impact of local control on survival

Slides:



Advertisements
Similar presentations
Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review  David.
Advertisements

Ewing sarcoma of the ribResults of an intergroup study with analysis of outcome by timing of resection  Robert C. Shamberger, MD, FACS, Michael P. LaQuaglia,
Photodynamic Laser Therapy for Lesions in the Airway
Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.
Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Local recurrence after surgery for non–small cell lung cancer: A recursive partitioning analysis of multi-institutional data  Chris R. Kelsey, MD, Kristin.
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database  Alex.
Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database  Alex.
The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation  Arman Kilic, MD,
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Pediatric tracheal surgery
Anastomotic complications after tracheal resection: Prognostic factors and management  Cameron D. Wright, MD, Hermes C. Grillo, MD, John C. Wain, MD,
The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer  Kyong-Ah Yoon,
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.
Detection of circulating tumor cells in patients with non–small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: A potential.
Survival after resection of synchronous non–small cell lung cancer
Tumors of the esophagogastric junction
Jean Paul A. Couetil, MDa, Didier P
Pretreatment Anemia Portends Poor Survival and Nonlocal Disease Progression in Patients with Stage I Non–Small Cell Lung Cancer Treated with Stereotactic.
Nael Martini, MDa, Manjit S. Bains, MDa, Michael E
Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis 
Outcomes in lung transplantation after previous lung volume reduction surgery in a contemporary cohort  Leah Backhus, MD, Jonathon Sargent, BS, Aaron.
Ugo Pastorino, MD, Marc Buyse, ScD, Godehard Friedel, MD, Robert J
Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation  R.Duane Davis,
Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors  Benny Weksler, MD, Anthony Holden, MD, Jennifer.
Lorenzo Spaggiari, MD, PhD, Ugo Pastorino, MD 
Survival and function after sleeve lobectomy for lung cancer
Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.
Michael Lanuti, MD, Pierre E
Ashok Muniappan, MD, John C. Wain, MD, Cameron D. Wright, MD, Dean M
Postintubation tracheal stenosis
Atrioventricular discordance: Results of repair in 127 patients
Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database 
Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.
Support Your Specialty
Thymic neuroendocrine carcinoma (carcinoid): A clinicopathologic study of fourteen cases  Vincent Thomas de Montpréville, MDa, Paolo Macchiarini, MDb,
Prognostic assessment of 1310 patients with non–small-cell lung cancer who underwent complete resection from 1980 to 1993  Kunihiko Inoue, MDa, Masami.
Eyad K. El-Najdawi, MDa, David J. Driscoll, MDa, Francisco J
Confusion still exists regarding postoperative delirium and its etiology after esophagectomy  Robert B. Cameron, MD  The Journal of Thoracic and Cardiovascular.
Intermediate-Term Outcome Of Mitral Reconstruction In Cardiomyopathy
Impact of a Multidisciplinary Thoracic Oncology Clinic on the Timeliness of Care  Richard F. Riedel, MD, Xiaofei Wang, PhD, Meg McCormack, PA-C, Eric Toloza,
Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis  Alessandro Marra, MD, PhD, Ludger Hillejan, MD,
Are discordant positron emission tomography and pathological assessments of the mediastinum in non–small cell lung cancer significant?  Daniel J. Tandberg,
Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence  Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,
Yuji Tachimori, MD, Hoichi Kato, MD, Hiroshi Watanabe, MD 
Should Large Cell Neuroendocrine Lung Carcinoma be Classified and Treated as a Small Cell Lung Cancer or with Other Large Cell Carcinomas?  John M. Varlotto,
Lymph Node Metastasis In Small Peripheral Adenocarcinoma Of The Lung
Esophageal Leiomyoma: A 40-Year Experience
Carcinoma of the esophagus: Prognostic significance of histologic type
O. S. Breathnach, MDa, D. J. Kwiatkowski, MD, PhDb, D. M
Development of a patient-centered aggregate score to predict survival after lung resection for non–small cell lung cancer  Alessandro Brunelli, MD, Michele.
Luis F. Tapias, MD, Douglas J. Mathisen, MD, Cameron D
The future of cardiac surgery training: A survival guide
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Primary repair is superior to initial palliation in children with atrioventricular septal defect and tetralogy of fallot  Hani K. Najm, MDa, Glen S. Van.
Thomas J. Kirby, MDa (by invitation), Michael J
Prognostic factors and long-term results after thymoma resection: A series of 307 patients  Jean-François Regnard, MDa, Pierre Magdeleinat, MDa, Christian.
Ewing sarcoma of the ribResults of an intergroup study with analysis of outcome by timing of resection  Robert C. Shamberger, MD, FACS, Michael P. LaQuaglia,
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Thomas M. Egan, MDa (by invitation), Frank C
Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found? 
The tp53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non–small cell lung.
Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD 
Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy  Tomas Gudbjartsson,
Nael Martini, MDa, Valerie W. Rusch, MDa, Manjit S. Bains, MDa, Mark G
Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms  Robert E. Merritt, MD, Douglas J. Mathisen,
Impact of neoadjuvant chemoradiotherapy followed by surgical resection on node- negative T3 and T4 non–small cell lung cancer  Benedict D.T. Daly, MD,
Kristin A. Higgins, MD, Junzo P. Chino, MD, Neal Ready, MD, Mark W
Presentation transcript:

Superior sulcus lung tumors: Impact of local control on survival Michael P. Hagan, MD, PhD a, Noah C. Choi, MDa, Douglas J. Mathisen, MDb, John C. Wain, MDb, Cameron D. Wright, MDb, Hermes C. Grillo, MDb  The Journal of Thoracic and Cardiovascular Surgery  Volume 117, Issue 6, Pages 1086-1094 (June 1999) DOI: 10.1016/S0022-5223(99)70244-8 Copyright © 1999 Mosby, Inc. Terms and Conditions

Fig. 1 Patient grouping according to the assigned treatment. RT, Radiation therapy; NSCCa, non–small cell carcinoma. *Eleven patients also received postoperative radiation therapy. The Journal of Thoracic and Cardiovascular Surgery 1999 117, 1086-1094DOI: (10.1016/S0022-5223(99)70244-8) Copyright © 1999 Mosby, Inc. Terms and Conditions

Fig. 2 Kaplan-Meier actuarial survival curves for the entire patient group. Confidence intervals (95%) are shown as broken lines. The Journal of Thoracic and Cardiovascular Surgery 1999 117, 1086-1094DOI: (10.1016/S0022-5223(99)70244-8) Copyright © 1999 Mosby, Inc. Terms and Conditions

Fig. 3 Kaplan-Meier actuarial overall and disease-specific survival curves for the patients undergoing combined surgery/radiation therapy. Confidence intervals were omitted to avoid confusion. The Journal of Thoracic and Cardiovascular Surgery 1999 117, 1086-1094DOI: (10.1016/S0022-5223(99)70244-8) Copyright © 1999 Mosby, Inc. Terms and Conditions

Fig. 4 Kaplan-Meier curve for local control at the first site of failure (actuarial) for patients treated with surgery and irradiation. The Journal of Thoracic and Cardiovascular Surgery 1999 117, 1086-1094DOI: (10.1016/S0022-5223(99)70244-8) Copyright © 1999 Mosby, Inc. Terms and Conditions